Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Hormone replacement therapy and cancer]

T Bjørge¹, C Tropé

¹Avdeling for gynekologisk onkologi, Det Norske Radiumhospital, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke

|June 10, 1997

Summary

Hormone replacement therapy (HRT) significantly lowers cardiovascular disease and fracture risks. While long-term use may slightly increase breast cancer risk, it may reduce colon cancer risk, and is no longer contraindicated for select cancer survivors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence.

Journal of internal medicine·2018

Same author

HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.

Gynecologic oncology·2017

Same author

Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival.

European journal of gynaecological oncology·2016

Same author

Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study.

British journal of cancer·2016

Same author

Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Same author

Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study.

British journal of cancer·2013

Area of Science:

Endocrinology
Oncology
Cardiovascular Medicine

Context:

Hormone replacement therapy (HRT) has been a subject of extensive research and debate over the past 25 years.
HRT demonstrates significant benefits in reducing cardiovascular diseases and osteoporotic fractures.
Concerns persist regarding cancer risks, particularly for patients with a history of breast or endometrial cancer.

Purpose:

To evaluate the multifaceted risks and benefits of hormone replacement therapy (HRT).
To clarify the association between HRT and various cancer types, including breast, endometrial, and colon cancer.
To assess the safety and efficacy of HRT in women with a history of specific cancers.

Summary:

HRT significantly reduces the risk of cardiovascular diseases and osteoporotic fractures.

Related Experiment Videos

Combined estrogen-progestin therapy does not elevate endometrial cancer risk compared to non-users.

Long-term HRT use is associated with a slight increase in breast cancer risk but a potential decrease in colon cancer risk.

HRT is no longer contraindicated for selected women with a history of endometrial or breast cancer, pending further research.

Impact:

Provides crucial insights for clinicians and patients regarding HRT's role in managing menopausal symptoms and associated health risks.
Highlights the need for personalized HRT prescriptions based on individual patient history and risk factors.
Underscores the necessity of prospective randomized trials to definitively assess HRT's impact on overall survival in cancer survivors.